SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in IXHL — Incannex Healthcare Inc.
CIK 1446194
BALA CYNWYD, PA
Position in IXHL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,178
New position
Shares Held
28,771
first reported quarter
Ownership
0.240%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 15 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in IXHL
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$62,040
PutShares
16,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. IXHL ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,504,358 | $108,103,165 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
88,579 | $47,994,759 | |
| 3 | LQDA |
Liquidia Corp
|
471,067 | $37,558,171 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,195,651 | $11,956,510 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,149,496 | $11,943,263 | |
| 6 | HROW |
Harrow, Inc.
|
190,116 | $8,074,226 | |
| 7 | VTRS |
Viatris Inc
|
295,261 | $4,688,744 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
1,021,777 | $4,587,778 |
All Filings in IXHL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,178 | 28,771 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $62,040 | 16,500 | Put | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||